The Abramson Cancer Center of the University of Pennsylvania
Ultima Vez Modificado: 5 de mayo del 2011
Video from The Focus On Head and Neck Cancers Conference, a full day designed to address the personal and medical issues facing those with head and neck cancers; including those in treatment, survivors, their loved ones, and caregivers.
Keynote Presentation: Taking Charge of your Cancer
Health Care Reform Briefing
Latest Advancements in the Treatment of
Oral Cavity and Tongue Cancer
Oropharynx - Throat Cancer
Larynx - Voice Box Cancer
Larynx - Voice Box Cancer pt2
Skull Base Cancer
Integrative Medicine & Wellness - Case Conference
Nutrition, Speech & Swallowing Issues
Sep 19, 2014 - The investigational drug alpelisib (previously known as BYL719) appears to inhibit activation of the pathway that leads to resistance to cetuximab, an anti-epidermal growth factor receptor agent used in the treatment of head and neck cancer. These findings were presented at the American Association for Cancer Research's special conference "Targeting the PI3K-mTOR Network in Cancer," held from Sept. 14 to 17 in Philadelphia.